業績｜論文・出版物｜目次｜
 

miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy

Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune response

Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates

Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation, J

Efficient gene delivery in human and rodent mast cells using adenovirus vectors

Innate immune response induced by gene delivery vectors

Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors

Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency

Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses

Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors

Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis

Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants

Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency

Downregulation of CD46 during muscle differentiation: implications for gene transfer to human skeletal muscle using group B adenoviruses

Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35

Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35

標的指向性を有するバイオコンジュゲート化アデノウイルスベクターの開発

遺伝子治療研究の動向

ウイルスベクター

アデノウイルスベクター